Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Mannitol → Docetaxel Mannitol
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Mannitol | HCID 6251 | — |
| 반응물 | Docetaxel | HCID 148124 | — |
| 생성물 | Docetaxel Mannitol | HCID 86641782 | — |
반응 단계
Lyophilization is performed to yield vials containing lyophilized cake comprising docetaxel and mannitol in a ratio of 1:1.5 to 1:3, preferably 1:1.8 to 1:2.7, more preferably 1:2.0 to 1:2.5, and most preferably 1:2.2. The amount of cake may vary, for example a 1:2.2 ratio may be obtained by a vial comprising 20 mg docetaxel and 44 mg mannitol, a vial comprising 80 mg docetaxel and 176 mg mannitol, or a vial comprising 120 mg docetaxel and 264 mg mannitol.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08541360B2 |
| 출처 데이터셋 | uspto-grants-2013_09 |
| ORD ID | ord-27e97dd5f81c4864a82e99c54caa86b2 |
| 출처 메모 | uspto-grants-2013_09 |